Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jul 14 2025 | Journal of Cardiac Failure Call for Papers: Focus Issue: Infiltrative and Inflammatory Cardiomyopathies HFSA News Journal of Cardiac Failure Read More Jul 14 2025 | Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension Industry News In The News Industry Read More Jul 14 2025 | U.S. FDA Approves KERENDIA® (finerenone) to Treat Patients With Heart Failure With Left Ventricular Ejection Fraction ≥40% Following Priority Review Industry News In The News Industry Read More Jul 8 2025 | Developments in Therapeutic Ketosis for Heart Failure Patients Examined in July 2025 issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More Jul 6 2025 | HFSA President's Update: July 2025 HFSA News President's Updates Read More Pagination First page « First Previous page ‹ Previous … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page Next › Last page Last »
Jul 14 2025 | Journal of Cardiac Failure Call for Papers: Focus Issue: Infiltrative and Inflammatory Cardiomyopathies HFSA News Journal of Cardiac Failure Read More
Jul 14 2025 | Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension Industry News In The News Industry Read More
Jul 14 2025 | U.S. FDA Approves KERENDIA® (finerenone) to Treat Patients With Heart Failure With Left Ventricular Ejection Fraction ≥40% Following Priority Review Industry News In The News Industry Read More
Jul 8 2025 | Developments in Therapeutic Ketosis for Heart Failure Patients Examined in July 2025 issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More
